Antibody response to GD3 ganglioside is independent of NKT cells

References

• Kronenberg M. Toward an understanding of NKT cell biology: progress and paradoxes. Annu Rev Immunol 2005; 23: 877–900
   PubMed Web of Science ®Google Scholar
• Bendelac A, Savage PB, Teyton L. The biology of NKT cells. Annu Rev Immunol 2007; 25: 297–336
   PubMed Web of Science ®Google Scholar
• Kawano T, Cui J, Koezuka Y, et al. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 1997; 278: 1626–9
   PubMed Web of Science ®Google Scholar
• Bendelac A, Lantz O, Quimby ME, et al. CD1 recognition by mouse NK1+ T lymphocytes. Science 1995; 268: 863–5
   PubMed Web of Science ®Google Scholar
• Lantz O, Bendelac A. An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4–8− T cells in mice and humans. J Exp Med 1994; 180: 1097–106
   PubMed Web of Science ®Google Scholar
• Van Kaer L. alpha-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles. Nature Rev 2005; 5: 31–42
   Google Scholar
• Wilson SB, Delovitch TL. Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity. Nature Rev 2003; 3: 211–22
   Google Scholar
• Chang DH, Osman K, Connolly J, et al. Sustained expansion of NKT cells and antigen-specific T cells after injection of alpha-galactosyl-ceramide loaded mature dendritic cells in cancer patients. J Exp Med 2005; 201: 1503–17
   PubMed Web of Science ®Google Scholar
• Toura I, Kawano T, Akutsu Y, et al. Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with alpha-galactosylceramide. J Immunol 1999; 163: 2387–91
   PubMed Web of Science ®Google Scholar
• Fischer K, Scotet E, Niemeyer M, et al. Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells. Proc Natl Acad Sci USA 2004; 101: 10685–90
   PubMed Web of Science ®Google Scholar
• Kinjo Y, Wu D, Kim G, et al. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 2005; 434: 520–5
   PubMed Web of Science ®Google Scholar
• Wu DY, Segal NH, Sidobre S, et al. Cross-presentation of disialoganglioside GD3 to natural killer T cells. J Exp Med 2003; 198: 173–81
   PubMed Web of Science ®Google Scholar
• Nasi ML, Meyers M, Livingston PO, et al. Anti-melanoma effects of R24, a monoclonal antibody against GD3 ganglioside. Melanoma Res 1997; 7(Suppl 2)S155–62
   Google Scholar
• Scott AM, Liu Z, Murone C, et al. Immunological effects of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma. Cancer Immun 2005; 5: 3
   PubMedGoogle Scholar
• Ritter G, Boosfeld E, Adluri R, et al. Antibody response to immunization with ganglioside GD3 and GD3 congeners (lactones, amide and gangliosidol) in patients with malignant melanoma. Int J Cancer 1991; 48: 379–85
   PubMed Web of Science ®Google Scholar
• Ragupathi G, Meyers M, Adluri S, et al. Phase I trial with GD3–lactone–KLH conjugate and immunological adjuvant QS-21 vaccine in malignant melanoma. Am Assoc Cancer Res 1997; 38: 398
   Google Scholar
• Takahashi T, Johnson TD, Nishinaka Y, et al. IgM anti-ganglioside antibodies induced by melanoma cell vaccine correlate with survival of melanoma patients. J Invest Dermatol 1999; 112: 205–9
   PubMed Web of Science ®Google Scholar
• Galli G, Pittoni P, Tonti E, et al. Invariant NKT cells sustain specific B cell responses and memory. Proc Natl Acad Sci USA 2007; 104: 3984–9
   PubMed Web of Science ®Google Scholar
• Lang GA, Exley MA, Lang ML. The CD1d-binding glycolipid alpha-galactosylceramide enhances humoral immunity to T-dependent and T-independent antigen in a CD1d-dependent manner. Immunology 2006; 119: 116–25
   PubMed Web of Science ®Google Scholar
• Cui J, Shin T, Kawano T, et al. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science 1997; 278: 1623–6
   PubMed Web of Science ®Google Scholar
• Galanos C, Luderitz O, Westphal O. Preparation and properties of antisera against the lipid-A component of bacterial lipopolysaccharides. Eur J Biochem 1971; 24: 116–22
   Google Scholar
• Chapman PB, Williams L, Salibi N, et al. A phase II trial comparing five dose levels of BEC2 anti-idiotypic monoclonal antibody vaccine that mimics GD3 ganglioside. Vaccine 2004; 22: 2904–9
   PubMedGoogle Scholar
• Livingston PO, Ritter G, Calves MJ. Antibody response after immunization with the gangliosides GM1, GM2, GM3, GD2 and GD3 in the mouse. Cancer Immunol Immunother 1989; 29: 179–84
   PubMed Web of Science ®Google Scholar
• Duthie MS, Kahn M, White M, et al. Critical proinflammatory and anti-inflammatory functions of different subsets of CD1d-restricted natural killer T cells during Trypanosoma cruzi infection. Infect Immun 2005; 73: 181–92
   PubMed Web of Science ®Google Scholar
• Kitamura H, Ohta A, Sekimoto M, et al. alpha-galactosylceramide induces early B-cell activation through IL-4 production by NKT cells. Cell Immunol 2000; 199: 37–42
   PubMed Web of Science ®Google Scholar
• Galli G, Nuti S, Tavarini S, et al. CD1d-restricted help to B cells by human invariant natural killer T lymphocytes. J Exp Med 2003; 197: 1051–7
   PubMed Web of Science ®Google Scholar
• Terabe M, Swann J, Ambrosino E, et al. A nonclassical non-V{alpha}14J{alpha}18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance. J Exp Med 2005; 202: 1627–33
   PubMed Web of Science ®Google Scholar
• Hansen DS, Siomos MA, De Koning-Ward T, et al. CD1d-restricted NKT cells contribute to malarial splenomegaly and enhance parasite-specific antibody responses. Eur J Immunol 2003; 33: 2588–98
   Google Scholar
• Schofield L, McConville MJ, Hansen D, et al. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science 1999; 283: 225–9
   PubMed Web of Science ®Google Scholar
• Molano A, Park SH, Chiu YH, et al. Cutting edge: the IgG response to the circumsporozoite protein is MHC class II-dependent and CD1d-independent: exploring the role of GPIs in NK T cell activation and antimalarial responses. J Immunol 2000; 164: 5005–9
   PubMed Web of Science ®Google Scholar